Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03326921||Recruiting||HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant||
||Other / Industry / NIH||
||24||All||up to 70 Years (Child, Adult, Older Adult)||NCT03326921||9716
|February 23, 2018||December 16, 2019||October 16, 2020||October 31, 2017||June 3, 2019||